TY - JOUR
T1 - A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy
AU - Androulakis, Ioannis
AU - Mestrom, Rob M.C.
AU - Christianen, Miranda E.M.C.
AU - Kolkman-Deurloo, Inger Karine K.
AU - van Rhoon, Gerard C.
PY - 2022
Y1 - 2022
N2 - In high-dose-rate brachytherapy (HDR-BT) for prostate cancer treatment, interstitial hyperthermia (IHT) is applied to sensitize the tumor to the radiation (RT) dose, aiming at a more efficient treatment. Simultaneous application of HDR-BT and IHT is anticipated to provide maximum radiosensitization of the tumor. With this rationale, the ThermoBrachyTherapy applicators have been designed and developed, enabling simultaneous irradiation and heating. In this research, we present a method to optimize the three-dimensional temperature distribution for simultaneous HDR-BT and IHT based on the resulting equivalent physical dose (EQDphys) of the combined treatment. First, the temperature resulting from each electrode is precomputed. Then, for a given set of electrode settings and a precomputed radiation dose, the EQDphys is calculated based on the temperature-dependent linear-quadratic model. Finally, the optimum set of electrode settings is found through an optimization algorithm. The method is applied on implant geometries and anatomical data of 10 previously irradiated patients, using reported thermoradiobiological parameters and physical doses. We found that an equal equivalent dose coverage of the target can be achieved with a physical RT dose reduction of 20% together with a significantly lower EQDphys to the organs at risk (p-value < 0.001), even in the least favorable scenarios. As a result, simultaneous ThermoBrachy-Therapy could lead to a relevant therapeutic benefit for patients with prostate cancer.
AB - In high-dose-rate brachytherapy (HDR-BT) for prostate cancer treatment, interstitial hyperthermia (IHT) is applied to sensitize the tumor to the radiation (RT) dose, aiming at a more efficient treatment. Simultaneous application of HDR-BT and IHT is anticipated to provide maximum radiosensitization of the tumor. With this rationale, the ThermoBrachyTherapy applicators have been designed and developed, enabling simultaneous irradiation and heating. In this research, we present a method to optimize the three-dimensional temperature distribution for simultaneous HDR-BT and IHT based on the resulting equivalent physical dose (EQDphys) of the combined treatment. First, the temperature resulting from each electrode is precomputed. Then, for a given set of electrode settings and a precomputed radiation dose, the EQDphys is calculated based on the temperature-dependent linear-quadratic model. Finally, the optimum set of electrode settings is found through an optimization algorithm. The method is applied on implant geometries and anatomical data of 10 previously irradiated patients, using reported thermoradiobiological parameters and physical doses. We found that an equal equivalent dose coverage of the target can be achieved with a physical RT dose reduction of 20% together with a significantly lower EQDphys to the organs at risk (p-value < 0.001), even in the least favorable scenarios. As a result, simultaneous ThermoBrachy-Therapy could lead to a relevant therapeutic benefit for patients with prostate cancer.
KW - Biological modeling
KW - Brachytherapy
KW - Hyperthermia
KW - Induced
KW - Interstitial hyperthermia
KW - Linear quadratic model
KW - Prostate
KW - Prostatic neoplasms
KW - Thermoradiotherapy
KW - Treatment plan optimization
UR - http://www.scopus.com/inward/record.url?scp=85125909440&partnerID=8YFLogxK
U2 - 10.3390/cancers14061425
DO - 10.3390/cancers14061425
M3 - Article
AN - SCOPUS:85125909440
SN - 2072-6694
VL - 14
JO - Cancers
JF - Cancers
IS - 6
M1 - 1425
ER -